Virginia Commonwealth University School of Medicine, Richmond, VA.
Division of Vascular Surgery at VCU Health, Richmond, VA.
J Vasc Surg Venous Lymphat Disord. 2024 May;12(3):101715. doi: 10.1016/j.jvsv.2023.101715.
Current management of axillosubclavian deep venous thrombosis (DVT) often uses thrombolysis for the DVT, prompt first rib removal, and occasional venoplasty or stenting. Our institution has increasingly used anticoagulation alone followed by interval first rib resection. We sought to analyze the effectiveness of this simplified technique.
Between September 2012 and April 2021, 27 patients were identified within the institution's electronic medical record as having undergone first rib resection for upper extremity DVT. Seven of these patients had undergone preoperative thrombolysis before referral and were excluded. Among the remaining 20 patients, preoperative clinic charts were evaluated for age, venous segment involvement, contralateral limb involvement, presence of documented hypercoagulable state, duration of preoperative and postoperative anticoagulation, and postoperative outcomes.
Of the 20 patients (mean age, 26.2 years; 13 males) presenting with acute axillosubclavian DVT, all patients had right (n = 8) or left (n = 12) arm swelling. Five patients had extremity pain and four had extremity discoloration. Ten had axillosubclavian vein involvement, 9 had subclavian vein involvement, and 1 had axillary vein involvement. Two patients were on oral contraceptives and no patients had any other diagnosed hypercoagulable conditions. The mean duration of preoperative and postoperative anticoagulation was 3.2 ± 2.6 months and 2.1 ± 2.1 months, respectively. Nineteen patients underwent supraclavicular first rib resection and 1 patient underwent transaxillary resection. Twelve patients (60%) demonstrated complete DVT resolution by venous duplex examination during the postoperative period and 8 patients (40%) demonstrated partial recanalization/chronic DVT. Complications included one hemothorax and one thoracic duct injury. All 20 patients remain asymptomatic without arm swelling, with a mean follow-up of 55.1 ± 34.7 months.
Among patients presenting with acute axillosubclavian DVT, anticoagulation alone followed by interval first rib resection proved to be successful in providing symptomatic relief in the short to medium term. By eliminating the need for preoperative thrombolysis and postoperative venograms, this potentially cost-saving algorithm simplifies our management for acute venous thoracic outlet syndrome while maintaining good clinical outcomes. Because this study only analyzed our management algorithm's effectiveness in the short to medium term, the long-term effectiveness of this treatment will need to be demonstrated.
目前,对于锁骨下臂丛深静脉血栓形成(DVT)的治疗常采用溶栓、及时切除第一肋骨、偶尔进行血管成形术或支架置入。本机构越来越多地采用单独抗凝,随后间隔切除第一肋骨。我们旨在分析这种简化技术的有效性。
2012 年 9 月至 2021 年 4 月,我们在机构的电子病历中确定了 27 例因上肢 DVT 而行第一肋骨切除术的患者。其中 7 例在转诊前接受了术前溶栓治疗,被排除在外。在剩余的 20 例患者中,我们评估了术前临床病历中的年龄、静脉节段受累情况、对侧肢体受累情况、是否存在有记录的高凝状态、术前和术后抗凝的持续时间以及术后结局。
在 20 例(平均年龄 26.2 岁;男性 13 例)急性锁骨下臂丛 DVT 患者中,所有患者均出现右(n=8)或左(n=12)手臂肿胀。5 例患者出现肢体疼痛,4 例患者出现肢体变色。10 例患者锁骨下静脉受累,9 例患者锁骨下静脉受累,1 例患者腋静脉受累。2 例患者正在服用口服避孕药,没有患者患有任何其他诊断出的高凝状态。术前和术后抗凝的平均持续时间分别为 3.2±2.6 个月和 2.1±2.1 个月。19 例患者行锁骨上第一肋骨切除术,1 例患者行经腋部切除术。术后静脉双功能超声检查显示,12 例(60%)患者完全再通,8 例(40%)患者部分再通/慢性 DVT。并发症包括 1 例血胸和 1 例胸导管损伤。所有 20 例患者均无症状,无手臂肿胀,平均随访时间为 55.1±34.7 个月。
在急性锁骨下臂丛 DVT 患者中,单独抗凝后间隔切除第一肋骨在短期至中期内可成功缓解症状。通过消除术前溶栓和术后血管造影的需要,这种潜在的节省成本的算法简化了我们对急性静脉胸廓出口综合征的管理,同时保持了良好的临床结局。由于本研究仅分析了我们的管理算法在短期至中期内的有效性,因此需要证明这种治疗的长期有效性。